Drawing for ONCOPHARM

USPTO serial 79063721

ONCOPHARM

Reviewed by CopyMark Law Group

Reg. 3728601Status 706Registered
Filing date
Status date
Registration date
Dec 22, 2009
Examiner
THOMAS, JULIE
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ONCOPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Garth E. Coviello

Garth E. Coviello Brown & Michaels, PC118 North Tioga Street4th FloorIthaca, NY 14850

Goods and services

ClassDescriptionStatusFirst use
009Computer programs and software for use by health professionals for permitting real time access to patient information to physicians, pharmacists and nurses and for scheduling office visits; Computer programs and software for use by health professionals for generating reports regarding biochemical and haematological control studies; Computer programs and software for use by health professionals for administering chemotherapy preparations and treatments to patients; Computer programs and software for use by health professionals for accurate patient treatment planning; Computer programs and software for use by health professionals for ensuring that each health professional in therapeutic chain complies with patient treatment protocol; Computer programs and software for use by health professionals for producing clinically valid data to support clinical decisions; Computer programs and software for use by health professionals in providing patients information regarding medication dosage and educational materials in the nature of tutorials in the field of medication side effectsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 9, 2020NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 9, 202071AGREGISTERED-SEC.71 ACCEPTED—
Jan 8, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 24, 2019ES71TEAS SECTION 71 RECEIVED—
Dec 22, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 12, 2018RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 9, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 8, 201671AGREGISTERED-SEC.71 ACCEPTED—
Jan 7, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 25, 2015ES71TEAS SECTION 71 RECEIVED—
Nov 25, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 21, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 14, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 13, 2010FIMPFINAL DISPOSITION PROCESSED—
Mar 22, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 22, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 6, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2009NPUBNOTICE OF PUBLICATION—
Sep 3, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 3, 2009ALIEASSIGNED TO LIE—
Aug 28, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 21, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 21, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 21, 2009ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 29, 2009CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 29, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 2, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 2, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 2, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2009RFNTREFUSAL PROCESSED BY IB—
Jan 30, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 30, 2009RFRRREFUSAL PROCESSED BY MPU—
Jan 29, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 28, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 23, 2009DOCKASSIGNED TO EXAMINER—
Jan 23, 2009NWAPNEW APPLICATION ENTERED—
Jan 22, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance